Monozygotic twins with severe myoclonic epilepsy in infancy discordant for clinical features

Sahoko Miyama1, Tomohide Goto, Yushi Inoue

  • 1Department of Neurology, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan. DWM48541@biglobe.ne.jp

Pediatric Neurology
|July 22, 2008
PubMed

Insights

Identical twins with severe myoclonic epilepsy in infancy showed different disease courses. Bacterial meningitis in one twin altered epilepsy progression and language development.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Severe myoclonic epilepsy in infancy (SMEI) is a severe genetic epilepsy with significant developmental impact.
  • Monozygotic twins typically exhibit highly similar clinical presentations due to identical genetics.

Observation:

  • Identical male twins with SMEI presented with concordant seizure onset, symptoms, and development until 38 months.
  • Clinical courses diverged afterward, with delayed myoclonus and preserved language in twin 1 compared to twin 2.

Findings:

  • Twin 1 developed bacterial meningitis at 35 months, coinciding with the divergence in clinical course.
  • Bacterial meningitis appeared to influence the manifestation of SMEI, delaying myoclonus and preventing language regression in twin 1.

Implications:

  • Environmental factors, such as infections, can significantly modify the clinical trajectory of genetically determined epilepsies.
  • This case highlights the complex interplay between genetic predisposition and environmental insults in neurodevelopmental disorders.

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...